Ohio University

skip to main content

Partnering with Industry

Research and Development Partnering Opportunities in Life Sciences

Company Scope Brief Description Areas of Interest
Abbvie Research & Innovation     Preclinical The  Compound Toolbox  provides compounds or probes for use in preclinical research across multiple therapeutic areas at no charge. Requests are submitted through the  Open Innovation Portal and a signed MTA is required before compounds will be shipped. Immunology
Oncology
Neurology
Hepatology
Cystic Fibrosis
Preclinical and clinical The  Investigator-Initiated Study (IIS) Program provides research support for academic and community-based physicians and researchers. Proposals are evaluated based on scientific merit, alignment with Abbvie’s areas of interest, and availability of funding. A research agreement must be signed prior to financial support being granted. Proposals are accepted according to a schedule with the exception of preclinical studies in pre-registration compounds and clinical studies in Hepatology/HCV and Oncology, which are done on a rolling basis. Proposals can be submitted here. Biotherapeutics
Hepatology
Immunology
Men's Health
Neuroscience
Oncology
Pancreatology
Renal
Women's Health
Amgen Academic Collaborations Preclinical Amgen will provide materials for non-human studies based upon  a research study plan submitted by the investigator.  A research agreement will be signed between Amgen and investigator’s institution. None specified
Astellas Investigator Sponsored Research  Clinical Investigators can submit requests for funding and/or drug support via the  Investigator Sponsored Research Portal. None specified
AstraZeneca Partnering Preclinical and clinical AstraZeneca  Externally Sponsored Research  will support interventional clinical research (Phase I-IV), observational research, and non-clinical research. Investigators can submit ESR proposals through  ES2ROS. Cardiovascular & metabolic diseases
Gastrointestinal
Infection
Neuroscience
Oncology
Respiratory, inflammation & autoimmunity
Preclinical and clinical AstraZeneca's  Open Innovation  platform provides for collaboration across all stages of drug discovery. This includes access to compound libraries and new molecular profiling capabilities. Investigators should access the specific program of interest through the  Open Innovation website  for proposal submission details. None specified
Bayer Pharmaceuticals Partnering Preclinical and clinical Bayer supports web-based crowd-sourcing initiatives to offer grants to support specific projects. This includes  Grants4TargetsGrants4LeadsGrants4Apps, and  PartnerYourAntibodies.  Bayer's research incubator,  CoLaborator, offers laboratory space and access to Bayer resources. Targets:
Oncology
Gynecology
Heart & Vascular Diseases
Specialty Lung Diseases
Kidney Diseases
Hemostatic & Acute Organ Disorders

PartnerYourAntibodies:
Cardiovascular
Oncology
Gynecology

Biogen Medical Research Clinical Biogen supports medical research in areas of interest relevant to their portfolio. Study proposals are submitted through the  online submission portal. Multiple sclerosis
Hemophilia
Biosimilars
Boehringer Ingelheim Pharmaceuticals Investigator Initiated Studies Clinical Boehringer Investigator Initiated Studies (IIS) Program supports research for products and therapeutic areas of interest through clinical and health outcomes research. Investigators can submit proposals through the  online submission site. Respiratory
Cardiovascular
Oncology
Endocrinology
Bristol-Myers Squibb Investigator-Sponsored Research Preclinical and clinical  Bristol-Myers Squibb Investigator-Sponsored Research (ISR) Program supports  clinicalnon-interventional, and  non-clinical research. In addition, investigators may also submit proposals related to Pediatric Research. Clinical and Non-Interventional:
Priority given to:
Cardiovascular/metabolics
Neuroscience
Cancer
Immunology
Virology
Celgene Investigator-Initiated Trials Clinical Celgene Investigator-Initiated Trials Program is interested in funding research that utilizes Celgene compounds to further advance a specific drug. Investigators can submit ideas through the  Celgene MATRIX system. None specified
Eisai Investigator Initiated Studies Program Clinical  Eisai's Investigator Initiated Studies (IIS) Program provides research grants via clinical supplies and/or funding for projects that align with Eisai's areas of interest or products. Investigators can begin submitting proposals by selecting the appropriate therapeutic area  here. Epilepsy
Obesity
Breast cancer
Chemotherapy-induced nausea and vomiting
Renal cell cancer
Soft tissue sarcoma
Thyroid cancer
Eli Lilly Scientific Innovation   Clinical Lilly  Investigator Initiated Research (IIR)  involves Lilly products that have been approved for marketing for at least one indication.  Immunology
Diabetes 
Oncology
Neurodegenerative diseases
Headache Pain
Genzyme Partnering Preclinical and clinical Genzyme is interested in considering proposals at any stage of development. None specified
Gilead Investigator Sponsored Research Clinical Gilead Investigator Sponsored Research (ISR) provides grants in therapeutic areas of interest. Investigators can submit proposals through the  online application form. HIV/AIDS
Liver disease
Hematology/oncology
Cardiovascular
Inflammation/respiratory
GlaxoSmithKline Investigator-Sponsored Studies Program Clinical Through the Investigator-Sponsored Studies Program, GSK may provide funding and/or materials to investigators seeking support. Proposals may be submitted through the  registration portal. Oncology- and HIV-specific proposals are handled via other mechanisms. None specified
Janssen Preclinical and clinical Janssen  Investigator-Initiated Studies (IIS)  will provide support for research that aligns with their vision and areas of interest. Investigators can submit proposals through the  online portal. Cardiovascular
Metabolics
Johnson & Johnson Innovation Preclinical and clinical J&J Innovation Centers are interested in exploring early stage therapeutic and vaccine technologies. Investigators can submit ideas through the  Idea Portal. Note that all ideas must have a patent filing. Pharmaceuticals:
Cardiovascular & metabolism
Immunology
Infectious diseases & vaccines
Neuroscience
Oncology

Medical Devices & Diagnostics:
Orthopaedics
Neurovascular surgery
Vision care
Diabetes care
Infection prevention
Diagnostics
Cardiovascular disease
Sports medicine
Aesthetics

Consumer:
Baby care
Skin care
Oral care
Wound care
Women's health

Medivation Investigator Sponsored Research Preclinical and clinical Through the Investigator-Sponsored Research (ISR) Program, investigators can receive funding and/or study drug supply in support of their research proposals. Proposals can be submitted through the  online portal. None specified
Merck KGaA Open Innovation Portal   Preclinical and clinical EMD Serono Open Innovation Portal provides access to several programs, including those that provide open source access to antibodies and compounds, a screening library, and open lab space. To submit a compound through the  Open Compound Sourcing Program,  a Participation and Material Supply Agreement must be signed by the institution. To access the  Mini Library, an EMD Serono Mini Library Agreement will be required if your application is approved. None specified
Preclinical and clinical EMD Serono  Grant for Growth Innovation (GGI) Program  provides support for projects that have the potential to advance understanding in the field of growth. Proposals are accepted during an annual RFP. Applicants can begin submitting a proposal by following the process described  here. Growth (in general)

Priority given to:
QOL improvment translational research
Impact of nutrition
Metabolic impact
Pathophysiology
Diagnosis and follow-up
Extremes in growth disorders
Biomarkers
Long-term metabolic impact of the "GH-IFG axis" activity

Novartis Partnering
Preclinical and clinical
Novartis  Investigator Initiated Trials (ITTs)  should address meaning scientific and/or clinical objectives supported by valid scientific designs. Investigators may request support in the form of funding, drug, or both. None specified
Preclinical and clinical
Novartis Pharmaceuticals  provides opportunities in several areas, including pharmaceuticals in development that have reached proof of concept in humans, new technology in drug delivery or in process scale-up/development, new technology that can improve an established, validated manufacturing process, and joint regional commercialization efforts for marketed pharmaceuticals. Opportunities can be submitted using the  online submission form. Opportunities may also be submitted for marketed or late-stage oncology diagnostics or companion diagnostics. None specified
Preclinical
Novartis Institutes for BioMedical Research (NIBR) provides opportunities for early-stage compounds and technologies in Novartis’ areas of interest. Proposals can be submitted via the  online submission form. None specified
Preclinical and clinical
Sandoz, the generic pharmaceuticals division of Novartis, provides opportunities to partner in generic and biosimilar medicine. Proposals should be emailed to Sandoz using the link provided
here.
None specified
Preclinical and clinical
Alcon, which provides leading eye care products, accepts opportunities for enhance its portfolio of pharmaceutical and surgical products. Proposals should be emailed to Alcon using the link provided  here.
None specified
Pfizer
Preclinical and clinical
Pfizer R&D’s  Investigator-Initiated Research Program  may provide funding and/or drug for preclinical or clinical studies. Requests can be submitted through the  submission website.
For investigators interested in obtaining a Pfizer pure substance compound through the  Compound Transfer Program, a Compound Transfer Agreement (CTA) will need to be executed. Initial requests should be submitted through the  INSPIIRE portal  for processing and approval.
None specified
Regeneron
Preclinical and clinical
The Regeneron  Investigator-Initiated Study (IIS) Program  provides support for studies focused on Regeneron products and drug or for preclinical studies focused on Regeneron’s areas of interest.
Investigators may also access Regeneron therapeutics candidates, animal models, cell lines and other technologies through  external academic research collaborations.
IIS:
Ophthalmic neovascular diseases
Cardiovascular
Inflammatory diseases
Auto-immune conditions

 

External collaborations:
None specified
Roche / Genentech
Preclinical and clinical
Scientific Project Support  provides funding for general research, translational research, other research or development projects, and/or other initiatives for academic institutions. Grants are subject to the Genentech Letter of Agreement which is signed after the application is approved. Investigators can apply for funding  here.
Investigators may also request reagents and mice from Genentech using the  MTA Request Form.
Scientific Project Support:
None specified but Genentech may post Call for Grant Notifications (CGN) to request projects in specific areas.
Sanofi
Preclinical and clinical
Sanofi  Investigator Sponsored Studies (ISS)  support preclinical and clinical studies aimed at the advancement of disease knowledge and potential treatments in therapeutic areas of interest to Sanofi US. Projects can be submitted  here. Diabetes
Vaccines & infectious diseases
Rare diseases
Immunology & inflammation
Cardiovascular & metabolism
Multiple sclerosis
Cancer
Neurodegenerative diseases
Animal health
Shire
Preclinical and clinical Shire’s  Investigator-Initiated Research (IIR) Program supports clinical and scientific investigation into the understanding of diseases of interest to Shire or relating to Shire’s products. Behavioral health
Hematology
Gastrointestinal disorders
Ophthalmic diseases
Hypoparathyroidism
Hereditary angioedema (HAE)
Gaucher disease
Fabry disease
Hunter syndrome
Adrenal insufficiency
Takeda
Preclinical and clinical
Investigator Initiated Sponsored Research (IISR) supports scientific advances in medicine and increasing understanding of important diseases related to Takeda’s compounds and therapeutic areas of interest. Support can be in the form of study drug and/or funding. IISR requests can be submitted  here. Oncology
Gastrointestinal
Central nervous system
Specialty cardiovascular
Vaccines
Vertex
Preclinical and clinical
Vertex  Investigator-Initiated Studies  supports the advancement of scientific and medical knowledge about cystic fibrosis through funding support or providing study drug. Nonclinical studies using Vertex compounds for in vitro assays or in vivo models are also eligible for support. Investigators can submit proposals through the  application website.
Investigators may request compounds for non-clinical studies by sending a request  here.
Cystic fibrosis
Fibrotic disorders
Neurodegenerative diseases
Oncology
Orphan diseases


For a PDF version of this table, please click  here.